Discomfort and Psychosocial Difficulties in Fibromyalgia

NCT ID: NCT02078791

Last Updated: 2014-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

66 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-07-31

Study Completion Date

2014-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The patients who were not pain control, are referred to the Chronic Pain Unit so its complexity is greater. Made two different interventions in three groups of people with fibromyalgia. In the first group will proceed to infiltrate the painful area with medication, in the second GPST (Group Problem Solving Technique) and the third group both techniques. GPST will want to identify problems that people associate with fibromyalgia, as well as proposed solutions and it they have been carried out successfully or not. Will be essential to identifying and solving problems and using techniques to increase assertiveness, self-esteem and eliminating negative thoughts. Observing if after performing any of these techniques (infiltration, GPST or both) there is a better quality of life, reduce thoughts of suicide, pain and improves sleep quality. We also analyzed the satisfaction or not with therapies received and perceived usefulness.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It is a clinical trial. STUDY SUBJECTS. By random sampling will distribute women diagnosed with fibromyalgia in three groups. 30 people are expected to include in each of the three groups. Group 1. Infiltration, GPST Group 2, Group 3 GPST+ Infiltration The sample size is approximately 30 so that alpha risk of 0.05, and a lower risk beta 0.2, 29 subjects needed to detect a difference equal to or greater than 0.25 units. It is assumed that the proportion in the control group is 0.8. has estimated a loss rate of 20% follow-up.

Fibromyalgia patients attending the chronic pain unit referred by family doctors and other specialists. These are patients who have painful symptoms that could not be controlled in the first level of health care or health centers.Not form part of the study all patients with fibromyalgia but only those who have discomfort in the cervical area preferably.To include in the study the patient acceptance of its participation is required by informed consent.Anesthesiologists assigned patients into three different groups according to the intervention takes place; infiltration, TRP (Problem Solving Therapy) or both interventions. When patients have met 8-10 start TRP group. Each group will be directed by a trained professional nursing. If we if we haven't enough sample will search in Fibromyalgia Associations.

The information of all variables are entered into a database (Excel) of which will be imported to a statistical program (SPSS) for analysis.

Qualitative variables were expressed as frequencies and percentages and quantitative mediated by central tendency and (mean and standard deviation) dispersion.The relationship between variables was analyzed by the χ2, comparison of means (t-student), analysis of variance (ANOVA) and Spearman, depending on the type of variable.Multivariate analysis will be performed to try to determine factors that may promote improved quality of life / patients.

It is considered that the difference between variables is significant when the significance level is less than or equal to 0.05 (p ≤ 0.05).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fibromyalgia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Botox infiltration

Botox infiltration in cervical region

Group Type EXPERIMENTAL

Botox infiltration

Intervention Type DRUG

botox cervical infiltration in a group

Psychology therapy

Problem solving group therapy

Group Type EXPERIMENTAL

Psychology therapy

Intervention Type BEHAVIORAL

Psychology problem solving therapy lead by specialized nurses.

Botox infiltration & psychology therapy

Botox infiltration in cervical region and problem solving group therapy.

Group Type EXPERIMENTAL

Botox infiltration & psychology therapy

Intervention Type OTHER

Botox infiltration in cervical region and psychology problem solving therapy lead by specialized nurses.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Botox infiltration

botox cervical infiltration in a group

Intervention Type DRUG

Psychology therapy

Psychology problem solving therapy lead by specialized nurses.

Intervention Type BEHAVIORAL

Botox infiltration & psychology therapy

Botox infiltration in cervical region and psychology problem solving therapy lead by specialized nurses.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

botox infiltration, and grup solving terapy group Problem solving group therapy Botox infiltration and problem solving group therapy.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosing Fibromyalgia.
* Diagnosing Fibromyalgia + other causative pathology of chronic pain (chronic and / or chronic low back pain neck pain).
* Acceptance of study participation by informed consent

Exclusion Criteria

* Severe disability that makes a first indication infiltration (disc herniation and / or lumbar spinal stenosis).
* cognitive Impairment
* Life expectancy less than 12 months
Minimum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Catalan Institute of Health

OTHER_GOV

Sponsor Role collaborator

Universidad Nacional de Educación a Distancia

OTHER

Sponsor Role collaborator

University Rovira i Virgili

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pilar Montesó Curto

Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

PILAR MONTESÓ, phD

Role: STUDY_DIRECTOR

University Rovira i Virgili

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Verge de la Cinta

Tortosa, Tarragona, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Related Links

Access external resources that provide additional context or updates about the study.

http://www.fibromyalgia.org

Click here for more information about this study: Clinical Trial of Fibromyalgya in Southern Catalonia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012LINE-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Chronic Widespread Pain
NCT04942132 UNKNOWN NA
Sensory Stimulation in Fibromyalgia
NCT03227952 COMPLETED NA